1. Yang, Zhigang, Xu, Tao, Xie, Tao, Xi, Gangming, Zhang, Xiaobiao. 2022. CDC42EP3 promotes glioma progression via regulation of CCND1. In Cell death & disease, 13, 290. doi:10.1038/s41419-022-04733-9. https://pubmed.ncbi.nlm.nih.gov/35365622/
2. Xu, Peng, Li, Xiaoxi, Tang, Chao, Wang, Tao, Xu, Jiaming. 2022. Deduction of CDC42EP3 suppress development and progression of osteosarcoma. In Experimental cell research, 412, 113018. doi:10.1016/j.yexcr.2022.113018. https://pubmed.ncbi.nlm.nih.gov/34998812/
3. Chen, Wenchao, Zhu, Yuanzeng, Zhang, Wei, Sun, Peichun, Wu, Gang. . CDC42EP3 is a key promoter involved in the development and progression of gastric cancer. In Carcinogenesis, 42, 1179-1188. doi:10.1093/carcin/bgab048. https://pubmed.ncbi.nlm.nih.gov/34111280/
4. Farrugia, Aaron J, Calvo, Fernando. 2016. Cdc42 regulates Cdc42EP3 function in cancer-associated fibroblasts. In Small GTPases, 8, 49-57. doi:10.1080/21541248.2016.1194952. https://pubmed.ncbi.nlm.nih.gov/27248291/
5. Li, Ding, Liang, Jiaming, Guo, Wenbin, Wu, Xuan, Zhang, Wenzhou. 2022. Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson's disease. In Frontiers in aging neuroscience, 14, 971528. doi:10.3389/fnagi.2022.971528. https://pubmed.ncbi.nlm.nih.gov/36062142/
6. Yan, Yuanliang, Liang, Qiuju, Xu, Zhijie, Yi, Qiaoli. 2021. Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration. In PeerJ, 9, e12171. doi:10.7717/peerj.12171. https://pubmed.ncbi.nlm.nih.gov/34616622/
智鼠故事 
